U.S. Food and Drug Administration
107K subscribers
Join us for a Vaccines and Related Biological Products Advisory Committee meeting to discuss Pfizer-BioNTech’s supplemental Biologics License Application for administration of a third dose, or “booster” dose, of the COVID-19 vaccine, Comirnaty, in individuals 16 years of age and older.
So it's about the approval for a booster of Comirnaty, and not the one in the US..? Did we conclude that that was indeed the case about Comirnaty not being available in the states..? I'm so sick of their mental gymnastics!
U.S. Food and Drug Administration 107K subscribers Join us for a Vaccines and Related Biological Products Advisory Committee meeting to discuss Pfizer-BioNTech’s supplemental Biologics License Application for administration of a third dose, or “booster” dose, of the COVID-19 vaccine, Comirnaty, in individuals 16 years of age and older.
So it's about the approval for a booster of Comirnaty, and not the one in the US..? Did we conclude that that was indeed the case about Comirnaty not being available in the states..? I'm so sick of their mental gymnastics!